Again, VCX2 was much less frequently expressed in cancers compared to GAGE and MAGE-A CT antigens, which we previously detected in 10-40% of tumors of multiple cancer types (e.g., melanoma, lung cancer, bladder cancer, and breast cancer) (33). Here, VCX2 is linked to urinary bladder carcinoma.